Skip to content
Prof. Dr. Mustafa Özdoğan · Medical Oncologist

CRISPR Can Analyze Why T Cells Remain Inactive Against Cancer and Enable Their Activation

CRISPR Can Analyze Why T Cells Remain Inactive Against Cancer and Enable Their Activation

The immune system is activated against cancer by immunotherapies, which offer results revolutionizing cancer treatment. Recently, besides immune checkpoints being targeted by drug-based immunotherapies, another goal is to turn patients' own immune cells into cancer fighters . One of the most important challenges in this field is that the complete genetic structure of immune cells and their associated pathways have not been completely clarified. In November 2018, Cell published a study developing a CRISPR-based system enabling detailed, rapid genetic analysis of each primary T cell taken from a patient. This development may pave the way for more effective, personalized immunotherapies.

Researchers named this CRISPR-developed technique SLICE . With SLICE, T cells were tested, yielding the following results:

  • Cancer immunotherapies are effective only in certain cancer types. Using SLICE, researchers discovered genes enabling T-cell proliferation. This may allow more patients to benefit from cancer immunotherapy.
  • Previously undiscovered using earlier techniques, genes enabling T-cell proliferation were identified. Researchers modified these genes in human T cells using CRISPR. In cell culture models, the modified T cells showed increased cancer-killing properties.
  • Genes enabling immune suppression in the tumor microenvironment were also identified. When these genes were inhibited (suppressed), T cells actively attacked tumors in the tumor microenvironment.

So What Does This Study Mean for Us?

  • An important technique has been developed to increase cancer immunotherapy's effectiveness. It may enable personalized and more effective immunotherapy medicines.
  • One of the main reasons cancer immunotherapy often fails is the tumor microenvironment. The tumor microenvironment, suppresses immune T cells. This technique may enable treatment strategies allowing T cells to overcome that suppression.
  • One limitation of T-cell immunotherapies was the incomplete knowledge of T-cell genetics. This technique allows every T cell from each patient to be analyzed quickly and easily.
  • We are beginning to see CRISPR's impact on cancer research. Modern medicine continues to develop effective cancer treatment strategies using genetics and many other scientific fields.

Sources

Eric Shifrut ve ark.
Genome-wide CRISPR Screens in Primary Human T Cells Reveal Key Regulators of Immune Function.
Cell, 15 November 2018

Appointment request

DROZDOGAN AI

Explore this article together

Ask about the article and read answers alongside published sources from our site.

DROZDOGAN AI

Drozdogan Assistant

CRISPR Can Analyze Why T Cells Remain Inactive Against Cancer and Enable Their Activation

Ask about the article and read answers alongside published sources from our site.

Conversation and privacy information

Drozdogan Assistant answers this conversation. Authorized site administrators may review it for quality. Do not share personal information.

Replies use OpenAI infrastructure. Questions and replies are processed by that service; conversation records are stored on our site. Do not share identifying, contact or personal health information.

0 / 1000

For information only; no personal diagnosis or treatment advice.

Related articles

Explore other articles on this topic.

Stay informed

Receive new articles and scientific updates by email.

Google Analytics runs on public pages independently of this window and may use analytics cookies. Your choice here controls external services only.

Cookie policy